Sphingosine 1‐phosphate induces the production of glial cell line‐derived neurotrophic factor and cellular proliferation in astrocytes

Sphingosine 1‐phosphate (S1P) is a platelet‐derived bioactive sphingolipid that evokes a variety of biological responses. To understand the role of S1P in the central nervous system, we have examined the effect of S1P on the production of glial cell line‐derived neurotrophic factor (GDNF) and growth regulation of cortical astrocytes from rat embryo. Moreover, we examined the possibility that the expression of GDNF is regulated differently in cultured astrocytes from the stroke‐prone spontaneously hypertensive rat (SHRSP) than in those from Wistar kyoto rats (WKY). The mRNA expression was quantitated by RT‐PCR based on the fluorescent TaqMan methodology. A new instrument capable of measuring fluorescence in real time was used to quantify gene amplification in astrocytes. GDNF protein was investigated by enzyme‐linked immunosorbent assay. S1P induced the expression of GDNF mRNA and the production of GDNF protein in a dose‐dependent manner in WKY astrocytes. Moreover, S1P increased cell numbers and induced the proliferation of astrocytes. In addition, the level of mRNA expression and protein production of GDNF was significantly lower in SHRSP than WKY astrocytes following exposure to S1P. These findings revealed that S1P augments GDNF protein production and cellular growth in astrocytes. Also, our results indicate that production in SHRSP astrocytes was attenuated in response to S1P compared with that observed in WKY. We conclude that S1P specifically triggers a cascade of events that regulate the production of GDNF and cell growth in astrocytes. Our results also suggest that the reduced expression of GDNF caused by S1P is a factor in the stroke proneness of SHRSP. GLIA 41:199–206, 2003. © 2003 Wiley‐Liss, Inc.

[1]  Y. Yamori,et al.  Morphological differentiation of endothelial cells co-cultured with astrocytes on type-I or type-IV collagen , 1992, Cell and Tissue Research.

[2]  Y. Yamori,et al.  Differential regulation of glial cell line‐derived neurotrophic factor (GDNF) mRNA expression during hypoxia and reoxygenation in astrocytes isolated from stroke‐prone spontaneously hypertensive rats , 2002, Glia.

[3]  L. Parada,et al.  Brain remodeling due to neuronal and astrocytic proliferation after controlled cortical injury in mice , 2001, Journal of neuroscience research.

[4]  Jisheng Han,et al.  Adenovirus-mediated GDNF protects cultured motoneurons from glutamate injury , 2001, Neuroreport.

[5]  M. Tuszynski,et al.  GDNF gene delivery to injured adult CNS motor neurons promotes axonal growth, expression of the trophic neuropeptide CGRP, and cellular protection , 2001, The Journal of comparative neurology.

[6]  J. Glowinski,et al.  Sphingosine‐1‐phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades , 2001, The European journal of neuroscience.

[7]  R. Töpper,et al.  Time course of glial proliferation and glial apoptosis following excitotoxic CNS injury , 2001, Brain Research.

[8]  T. Ohmori,et al.  Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells , 2000 .

[9]  Koichi Sato,et al.  Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. , 2000, Analytical biochemistry.

[10]  M. Ui,et al.  Sphingosine 1-phosphate induces expression of early growth response-1 and fibroblast growth factor-2 through mechanism involving extracellular signal-regulated kinase in astroglial cells. , 1999, Brain research. Molecular brain research.

[11]  C. Conover,et al.  Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. , 1999, Cancer research.

[12]  A. Barr,et al.  Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins* , 1999, The Journal of Biological Chemistry.

[13]  E. Goetzl,et al.  Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells. , 1999, Cancer research.

[14]  P. Dash,et al.  Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes , 1999, Neuroscience.

[15]  S. Spiegel,et al.  Enzymatic measurement of sphingosine 1-phosphate. , 1999, Analytical biochemistry.

[16]  Y. Yamori,et al.  Vitamin E prevents apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[17]  N. Kadowaki,et al.  Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.

[18]  E. Goetzl,et al.  Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  Y. Yamori,et al.  Vitamin E prevents apoptosis in cortical neurons during hypoxia and oxygen reperfusion. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[20]  W. Steers,et al.  Arterial nerve growth factor (NGF) mRNA, protein, and vascular smooth muscle cell NGF secretion in hypertensive and hyperactive rats. , 1998, Experimental cell research.

[21]  Y. Itoyama,et al.  Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. , 1998, Stroke.

[22]  M. Dragunow,et al.  The role of neuronal growth factors in neurodegenerative disorders of the human brain , 1998, Brain Research Reviews.

[23]  R. Gamelli,et al.  Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. , 1998, The American journal of pathology.

[24]  S. Tsang,et al.  Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. K. Malhotra,et al.  Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.

[26]  Y. Igarashi,et al.  Exogenous sphingosine 1-phosphate induces neurite retraction possibly through a cell surface receptor in PC12 cells. , 1997, Biochemical and biophysical research communications.

[27]  A. Ho,et al.  Regulation of Astroglial-Derived Dopaminergic Neurotrophic Factors by Interleukin-1β in the Striatum of Young and Middle-Aged Mice , 1997, Experimental Neurology.

[28]  S. Spiegel,et al.  Involvement of Sphingosine 1-Phosphate in Nerve Growth Factor-Mediated Neuronal Survival and Differentiation , 1997, The Journal of Neuroscience.

[29]  D. Hilt,et al.  Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease , 1997, Experimental Neurology.

[30]  C. Heid,et al.  A novel method for real time quantitative RT-PCR. , 1996, Genome research.

[31]  H. D. Cavanagh,et al.  Effects of basic FGF and TGF beta 1 on F-actin and ZO-1 organization during cat endothelial wound healing. , 1996, Cornea.

[32]  S. Hakomori,et al.  Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. , 1995, Blood.

[33]  G. Piazza,et al.  Lysophosphatidic Acid Induction of Transforming Growth Factors α and β: Modulation of Proliferation and Differentiation in Cultured Human Keratinocytes and Mouse Skin , 1995 .

[34]  R. Plunkett,et al.  Time course of ciliary neurotrophic factor mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatum , 1995, Journal of neuroscience research.

[35]  G. Piazza,et al.  Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. , 1995, Experimental cell research.

[36]  L. Olson,et al.  Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. , 1994, Brain research. Molecular brain research.

[37]  I. Black,et al.  Regional and Cell-Specific Expression of GDNF in Rat Brain , 1993, Experimental Neurology.

[38]  J. Fawcett,et al.  Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons—i. Effectsin vitro , 1993, Neuroscience.

[39]  S. Varon,et al.  Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[41]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[42]  J. Fawcett,et al.  Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--I. Effects in vitro. , 1993, Neuroscience.

[43]  K. Unsicker,et al.  Basic fibroblast growth factor (bFGF) and rat C6 glioma cells: Regulation of expression, absence of release, and response to exogenous bFGF , 1990, Glia.

[44]  M. Schwartz,et al.  Dichotomy of the glial cell response to axonal injury and regeneration , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  K. McCarthy,et al.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue , 1980, The Journal of cell biology.

[46]  A. Nagaoka,et al.  Genetic predisposition to stroke in spontaneously hypertensive rats. , 1976, The American journal of physiology.

[47]  Y. Yamori.  Importance of genetic factors in stroke: an evidence obtained by selective breeding of stroke-prone and -resistant SHR. , 1975, Japanese circulation journal.

[48]  K. Okamoto.  Establishment of the strokeprone spontaneously hypertensive rat (SHR) , 1972 .